BIOCHEMICAL SOCIETY TRANSACTIONS sterone or [16B-"H]betamethasone was given at a dose of 0.23pmol/kg body wt. by intraperitoneal or intravenous route, and bile samples were collected at 30min intervals. In some experiments the animals were pretreated with daily doses (100mg/kg body wt., intraperitoneally) of phenobarbital for 3 consecutive days. In the isolated-liver perfusion experiments tissue-culture medium 199 (100ml) containing goat erythrocytes (haematocrit 35%) and bovine serum albumin (2Sg/lOOml) was used as the perfusion medium.
sterone or [16B-"H]betamethasone was given at a dose of 0.23pmol/kg body wt. by intraperitoneal or intravenous route, and bile samples were collected at 30min intervals. In some experiments the animals were pretreated with daily doses (100mg/kg body wt., intraperitoneally) of phenobarbital for 3 consecutive days. In the isolated-liver perfusion experiments tissue-culture medium 199 (100ml) containing goat erythrocytes (haematocrit 35%) and bovine serum albumin (2Sg/lOOml) was used as the perfusion medium.
The flow rate was carefully regulated at 0.72ml/min per g of liver under a constant head (35cm) of the perfusate. An hour after the perfusion began, the radioactive steroid (0.13pmol) was added to the reservoir, and bile samples were collected at 30min intervals. Samples (0.2ml) of the perfusion medium were withdrawn from points just before and after the liver at various time-intervals (5min-5 h) for radioactivity determination, The pooled bile samples were extracted twice with 1.5 vol. of ethyl acetate for the separation of unconjugated steroids.
Our results (Figs. 1 and 2) show that, both in the bile-fistulated animals and in the perfused liver, corticosterone is very rapidly excreted in the bile. In 5 h the cumulative biliary excretion (%+ s.E.M.) was found to be 85.4f3.8 and 92.5k1.4 of the dose respectively.
The rates of excretion ( %+s.E.M.) of betamethasone in uiuo and in the isolated perfused liver weresimilar (44.Ok 1.3and41.6k4.0) but considerably lower than therates observed for corticosterone excretion ( Figs. 1 and 2) .
This difference between corticosterone and betamethasone could not be attributed to the differences in their rates of uptake by the liver, as in the bile-fistulated animals the excretion patterns were the same whether the steroids were given by intraperitoneal or intravenous routes. Further, in the perfusion studies, [3H]corticosterone and [3H]betamethasone disappeared at about the same rate from the perfusion medium.
Corticosterone is extensively metabolized by the liver and excreted in the bile primarily as conjugates (Eriksson & Gustafsson, 1971) . Although the hepatic metabolism of betamethasone has not been investigated, it is known from studies in uitro that structural modification of the corticosteroid molecule decreases its rate of metabolism by the liver (Fotherby & James, 1972) . That metabolism may be implicated in the smaller biliary excretion of betamethasone is indicated by our finding that pretreatment of rats with the hepatic enzyme inducer phenobarbital enhanced the biliary excretion of betamethasone, and this was not attributable to changes in the bile flow. The fractionation of the metabolites in the bile showed that, whereas only 2-3 % of the corticosterone metabolites in the bile was present as unconjugated steroids, the corresponding value for betamethasone was 11-17%. In view of these differing patterns of excretion, the difficulty of collecting serial urine samples from a conscious rat over a 6 h period and the possibility of other major routes of elimination, cannulation studies (Hearse et al., 1969) were carried out. In these experiments, each of the' three labelled forms of streptozotocin (dissolved in 0.01 M-citrate buffer, pH4.5) was separately administered (70mg/kg) to anaesthetized (15mg of pentobarbitone sodium/kg) rats via a cannula implanted in the jugular vein. Urine and bile samples were collected, from cannulae implanted in the ureters and bile duct, at specific intervals for a total period of 6 h. Six rats were used for each labelled form of the drug. The results are shown in Table 1 .
Several interesting points are apparent from theresults. First, the urine collected during first 1 h after the administration of the drug contained the highest proportion of excreted radioactivity (approx. 34% with [3'-Me-'4C]streptozotocin and approx. 40% with For metabolism studies urine was collected over 6h period from both cannulated and conscious animals (there is no difference in the excretion or metabolism of streptozotocin under these conditions). Urine samples were subjected to t.1.c. (cellulose MN 300 UVZs4; 0.lmm thickness) with two solvent systems (see Table 2 ), and radioactive compounds were located by using both spark-chamber and radioautographic techniques. With [3'-Me-14C]streptozotocin only unchanged streptozotocin could be detected in the 6h urine samples. In contrast, with [l-14C]streptozotocin and [2'-14C]streptozotocin, in addition to substantial amounts of unchanged streptozotocin, two major metabolites and one minor metabolite were detected. A time-course study with cannulated rats revealed that, in contrast with unchanged streptozotocin, where the peak of maximum excretion occurred after 10-20min, the major metabolites were maximally excreted after 60-90min. The close similarity, both qualitatively and quantitatively, in the excretion profiles for [l-14C]streptozotocin and [2'-14C]streptozotocin in experiments with both cannulated and conscious animals may suggest a similar metabolic fate for the respective radiolabelled carbon atoms. This possibility was further reinforced by the observation that both [l-14C]streptozotocin and [2'-14C]streptozotocin produced unchanged streptozotocin (S) and two major metabolites each (M1 and M2, and M3 and M4 respectively) and one minor metabolite each (Ms and Ms respectively), and that these metabolites exhibited identical Rp values (Table 2) and on isolation were shown to co-chromatograph in several solvent systems.
These results, coupled with the observation of a different excretion profile and lack of any radiolabelled metabolites (other than unchanged streptozotocin) in the urine for [3'-Me-14C]streptozotocin, suggest that the metabolism of streptozotocin must involve molecular cleavage between its 2'-carbon atom and its 3'-methyl group and the retention of the latter. Examination of the molecular structure and stability of the drug suggests that the bond between 2'-carbon and the N-methyl nitrogen may be very susceptible to scission. Such an event would be consistent with the observed incorporation of the l-I4C-and 2'-14C-carbon atoms into common metabolites and would also be compatible with known biological degradation patterns for N-nitrosoureido compounds (Lawley & Shah, 1972) . By using preparative-layer chromatography, attempts were made to isolate and identify the major metabolites MI, M2, M3 and M4. The attempts were hampered by the fact that these metabolites were present in small quantities, they exhibited very similar chromatographic migrations and, further, as a result of the streptozotocin-induced diabetes, glucose was present in the urine and this co-chromatographed with the metabolites and contaminated all preparations.
I n an attempt to overcome these difficulties, and also to evaluate the possibility of preparing greater quantities of the metabolites, a study in vitro of the metabolism of [1-I4C]-and [2'-14C]-streptozotocin was undertaken. Rat liver (log) was homogenized in 0.01 Mphosphate buffer, pH7.4 (lOOml), in a Waring blender and was centrifuged at lOOOOOg for 1 h a t 4°C. Portions (40ml) of the supernatant were incubated with [l-14C]streptozotocin (50mg) and [2'-14C]streptozotocin (50mg) at 37°C for 6h. T.1.c. of the incubation mixture revealed quantitative conversion of streptozotocin into metabolites that were identical with those obtained in v i m .
In an attempt to produce even larger quantities of the metabolites and also to confirm
